French scientists have invented the drug "Alirocoumab", which reduces the level of cholesterol (harmful) in the blood and reduces the risk of heart attack by 15%
On its Web site, MedicalXpress published a scientific article illustrating the features of the
Alirocoumab" compound that prolongs life and reduces the risk of premature death
Alirocoumab belongs to the PCSK9 inhibitor class of monoclonal antibodies and triggers an immune system attack in the body against a specific protein in the liver responsible for the production of PCSK9 in people with high levels of harmful cholesterol
Taking this drug for two years periodically reduces the risk of premature death by 29%
0 Comments